{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T11:25:11Z","timestamp":1761823511409},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2012,8,8]],"date-time":"2012-08-08T00:00:00Z","timestamp":1344384000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Childs Nerv Syst"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1007\/s00381-012-1792-y","type":"journal-article","created":{"date-parts":[[2012,8,7]],"date-time":"2012-08-07T12:27:43Z","timestamp":1344342463000},"page":"1495-1503","source":"Crossref","is-referenced-by-count":17,"title":["The Fgfr2 W290R mouse model of Crouzon syndrome"],"prefix":"10.1007","volume":"28","author":[{"given":"S.-G.","family":"Gong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,8,8]]},"reference":[{"key":"1792_CR1","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/ejhg.2010.235","volume":"19","author":"D Johnson","year":"2011","unstructured":"Johnson D, Wilkie AOM (2011) Craniosynostosis. Eur J Hum Genet 19:369\u2013376","journal-title":"Eur J Hum Genet"},{"key":"1792_CR2","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1002\/ajmg.a.31905","volume":"143A","author":"AOM Wilkie","year":"2007","unstructured":"Wilkie AOM, Bochukova EG, Hansen RMS, Taylor IB, Sahan VR-E et al (2007) Clinical dividends from the molecular genetic diagnosis of craniosynostosis. Am J Med Genet A 143A:1941\u20131949","journal-title":"Am J Med Genet A"},{"key":"1792_CR3","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.cytogfr.2005.03.001","volume":"16","author":"AOM Wilkie","year":"2005","unstructured":"Wilkie AOM (2005) Bad bones, absent smell, selfish testes: the pleiotropic consequences of human FGF receptor mutations. Cytokine Growth Factor Rev 16:187\u2013203","journal-title":"Cytokine Growth Factor Rev"},{"key":"1792_CR4","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/0092-8674(93)90379-5","volume":"75","author":"EW Jabs","year":"1993","unstructured":"Jabs EW, M\u00fcller U, Li X, Ma L, Luo W et al (1993) A mutation in the homeodomain of the human MSX2 gene in a family affected with autosomal dominant craniosynostosis. Cell 75:443\u2013450","journal-title":"Cell"},{"key":"1792_CR5","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1111\/j.1469-7580.2005.00475.x","volume":"207","author":"GM Morriss-Kay","year":"2005","unstructured":"Morriss-Kay GM, Wilkie AOM (2005) Growth of the normal skull vault and its alteration in craniosynostosis: insights from human genetics and experimental studies. J Anat 207:637\u2013653","journal-title":"J Anat"},{"key":"1792_CR6","doi-asserted-by":"crossref","first-page":"e391","DOI":"10.1542\/peds.2009-3491","volume":"126","author":"AOM Wilkie","year":"2010","unstructured":"Wilkie AOM, Byren JC, Hurst JA, Jayamohan J, Johnson D et al (2010) Prevalence and complications of single-gene and chromosomal disorders in craniosynostosis. Pediatrics 126:e391\u2013e400","journal-title":"Pediatrics"},{"key":"1792_CR7","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/(SICI)1098-1004(1999)14:2<115::AID-HUMU3>3.0.CO;2-2","volume":"14","author":"MR Passos-Bueno","year":"1999","unstructured":"Passos-Bueno MR, Wilcox WR, Jabs EW, Serti\u00e9 AL, Alonso LG et al (1999) Clinical spectrum of fibroblast growth factor receptor mutations. Hum Mutat 14:115\u2013125","journal-title":"Hum Mutat"},{"issue":"3","key":"1792_CR8","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/sj.ejhg.5201558","volume":"14","author":"E Lajeunie","year":"2006","unstructured":"Lajeunie E, Heuertz S, El Ghouzzi V, Martinovic J, Renier D et al. (2006) Mutation screening in patients with syndromic craniosynostoses indicates that a limited number of recurrent FGFR2 mutations accounts for severe forms of Pfeiffer syndrome. Eur J Hum Genet 14(3):289\u2013298.","journal-title":"Eur J Hum Genet"},{"key":"1792_CR9","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1159\/000115037","volume-title":"Frontiers in oral biology\u2014craniofacial sutures: development, disease and treatment","author":"MK Hajihosseini","year":"2008","unstructured":"Hajihosseini MK (2008) Fibroblast growth factor signaling in ranial sutrue development and pathogenesis. In: Rice DP (ed) Frontiers in oral biology\u2014craniofacial sutures: development, disease and treatment. Karger, Basel, pp 160\u2013177"},{"key":"1792_CR10","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1101\/gad.990702","volume":"16","author":"DM Ornitz","year":"2002","unstructured":"Ornitz DM, Marie PJ (2002) FGF signaling pathways in endochondral and intramembranous bone development and human genetic disease. Genes Dev 16:1446\u20131465","journal-title":"Genes Dev"},{"key":"1792_CR11","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.ydbio.2005.09.011","volume":"287","author":"B Thisse","year":"2005","unstructured":"Thisse B, Thisse C (2005) Functions and regulations of fibroblast growth factor signaling during embryonic development. Dev Biol 287:390","journal-title":"Dev Biol"},{"key":"1792_CR12","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/jcp.1041570202","volume":"157","author":"M Chaudhuri","year":"1993","unstructured":"Chaudhuri M, Moscatelli D, Basilico C (1993) Involvement of the conserved acidic amino acid domain of FGF receptor 1 in ligand-receptor interaction. J Cell Physiol 157:209\u2013216","journal-title":"J Cell Physiol"},{"key":"1792_CR13","first-page":"1195","volume":"6","author":"A Eisemann","year":"1991","unstructured":"Eisemann A, Ahn J, Graziani G, Tronick S, Ron D (1991) Alternative splicing generates at least five different isoforms of the human basic-FGF receptor. Oncogene 6:1195\u20131202","journal-title":"Oncogene"},{"key":"1792_CR14","first-page":"979","volume":"6","author":"P Champion-Arnaud","year":"1991","unstructured":"Champion-Arnaud P, Ronsin C, Gilbert E, Gesnel M, Houssaint E et al (1991) Multiple mRNAs code for proteins related to the BEK fibroblast growth factor receptor. Oncogene 6:979\u2013987","journal-title":"Oncogene"},{"key":"1792_CR15","doi-asserted-by":"crossref","first-page":"11620","DOI":"10.1016\/S0021-9258(19)78170-8","volume":"269","author":"AT Chellaiah","year":"1994","unstructured":"Chellaiah AT, McEwen DG, Werner S, Xu J, Ornitz DM (1994) Fibroblast growth factor receptor (FGFR) 3. Alternative splicing in immunoglobulin-like domain III creates a receptor highly specific for acidic FGF\/FGF-1. J Biol Chem 269:11620\u201311627","journal-title":"J Biol Chem"},{"key":"1792_CR16","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1128\/MCB.12.1.82","volume":"12","author":"S Werner","year":"1992","unstructured":"Werner S, Duan DS, de Vries C, Peters KG, Johnson DE et al (1992) Differential splicing in the extracellular region of fibroblast growth factor receptor 1 generates receptor variants with different ligand-binding specificities. Mol Cell Biol 12:82\u201388","journal-title":"Mol Cell Biol"},{"key":"1792_CR17","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1006\/dbio.1993.1205","volume":"158","author":"A Orr-Urtreger","year":"1993","unstructured":"Orr-Urtreger A, Bedford MT, Burakova T, Arman E, Zimmer Y et al (1993) Developmental localization of the splicing alternatives of fibroblast growth factor receptor-2 (FGFR2). Dev Biol 158:475\u2013486","journal-title":"Dev Biol"},{"key":"1792_CR18","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S0014-5793(00)02409-1","volume":"489","author":"A Hanneken","year":"2001","unstructured":"Hanneken A (2001) Structural characterization of the circulating soluble FGF receptors reveals multiple isoforms generated by secretion and ectodomain shedding. FEBS Lett 489:176\u2013181","journal-title":"FEBS Lett"},{"key":"1792_CR19","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1093\/emboj\/17.6.1642","volume":"17","author":"G Celli","year":"1998","unstructured":"Celli G, LaRochelle WJ, Mackem S, Sharp R, Merlino G (1998) Soluble dominant-negative receptor uncovers essential roles for fibroblast growth factors in multi-organ induction and patterning. EMBO J 17:1642\u20131655","journal-title":"EMBO J"},{"key":"1792_CR20","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1042\/BJ20100884","volume":"436","author":"LM Wheldon","year":"2011","unstructured":"Wheldon LM, Khodabukus N, Patey SJ, Smith TG, Heath JK et al (2011) Identification and characterization of an inhibitory fibroblast growth factor receptor 2 (FGFR2) molecule, up-regulated in an Apert syndrome mouse model. Biochem J 436:71\u201381","journal-title":"Biochem J"},{"key":"1792_CR21","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/sj.ejhg.5201558","volume":"14","author":"E Lajeunie","year":"2006","unstructured":"Lajeunie E, Heuertz S, El Ghouzzi V, Martinovic J, Renier D et al (2006) Mutation screening in patients with syndromic craniosynostoses indicates that a limited number of recurrent FGFR2 mutations accounts for severe forms of Pfeiffer syndrome. Eur J Hum Genet 14:289\u2013298","journal-title":"Eur J Hum Genet"},{"key":"1792_CR22","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.neuron.2011.08.002","volume":"71","author":"G Fo","year":"2011","unstructured":"Fo G, Cl Z (2011) From cradle to grave: the multiple roles of fibroblast growth factors in neural development. Neuron 71:574\u2013588","journal-title":"Neuron"},{"key":"1792_CR23","doi-asserted-by":"crossref","first-page":"3731","DOI":"10.1242\/dev.037689","volume":"137","author":"K Dorey","year":"2010","unstructured":"Dorey K, Amaya E (2010) FGF signalling: diverse roles during early vertebrate embryogenesis. Development 137:3731\u20133742","journal-title":"Development"},{"key":"1792_CR24","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1042\/BJ20101603","volume":"437","author":"J Wesche","year":"2011","unstructured":"Wesche J, Haglund K, Haugsten E (2011) Fibroblast growth factors and their receptors in cancer. Biochem J 437:199\u2013213","journal-title":"Biochem J"},{"key":"1792_CR25","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1242\/dev.124.14.2829","volume":"124","author":"BG Ciruna","year":"1997","unstructured":"Ciruna BG, Schwartz L, Harpal K, Yamaguchi TP, Rossant J (1997) Chimeric analysis of fibroblast growth factor receptor-1 (Fgfr1) function: a role for FGFR1 in morphogenetic movement through the primitive streak. Development 124:2829\u20132841","journal-title":"Development"},{"key":"1792_CR26","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/ng0496-390","volume":"12","author":"JS Colvin","year":"1996","unstructured":"Colvin JS, Bohne BA, Harding GW, McEwen DG, Ornitz DM (1996) Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3. Nat Genet 12:390\u2013397","journal-title":"Nat Genet"},{"key":"1792_CR27","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1242\/dev.127.3.483","volume":"127","author":"L Moerlooze De","year":"2000","unstructured":"De Moerlooze L, Spencer-Dene B, Revest J, Hajihosseini M, Rosewell I et al (2000) An important role for the IIIb isoform of fibroblast growth factor receptor 2 (FGFR2) in mesenchymal-epithelial signalling during mouse organogenesis. Development 127:483\u2013492","journal-title":"Development"},{"key":"1792_CR28","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.1101\/gad.8.24.3045","volume":"8","author":"CX Deng","year":"1994","unstructured":"Deng CX, Wynshaw-Boris A, Shen MM, Daugherty C, Ornitz DM et al (1994) Murine FGFR-1 is required for early postimplantation growth and axial organization. Genes Dev 8:3045\u20133057","journal-title":"Genes Dev"},{"key":"1792_CR29","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1002\/dvdy.22314","volume":"239","author":"S Mai","year":"2010","unstructured":"Mai S, Wei K, Flenniken A, Adamson SL, Rossant J et al (2010) The missense mutation W290R in Fgfr2 causes developmental defects from aberrant IIIb and IIIc signaling. Dev Dyn 239:1888\u20131900","journal-title":"Dev Dyn"},{"key":"1792_CR30","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1093\/hmg\/4.6.1077","volume":"4","author":"M Oldridge","year":"1995","unstructured":"Oldridge M, Wilkie AOM, Sianey SF, Poole MD, Pulleyn LJ et al (1995) Mutations in the third immunoglobulin domain of the fibroblast growth factor receptor-2 gene in Crouzon syndrome. Hum Mol Genet 4:1077\u20131082","journal-title":"Hum Mol Genet"},{"key":"1792_CR31","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1093\/hmg\/4.7.1229","volume":"4","author":"W-J Park","year":"1995","unstructured":"Park W-J, Meyers GA, Li X, Theda C, Day D et al (1995) Novel FGFR2 mutations in Crouzon and Jackson-Weiss syndromes show allelic heterogeneity and phenotypic variability. Hum Mol Genet 4:1229\u20131233","journal-title":"Hum Mol Genet"},{"key":"1792_CR32","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/(SICI)1098-1004(1996)8:4<386::AID-HUMU18>3.0.CO;2-Z","volume":"8","author":"D Steinberger","year":"1996","unstructured":"Steinberger D, Mulliken JB, M\u00fcller U (1996) Crouzon syndrome: previously unrecognized deletion, duplication, and point mutation within FGFR2 gene. Hum Mutat 8:386\u2013390","journal-title":"Hum Mutat"},{"key":"1792_CR33","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1007\/s004390050413","volume":"99","author":"M Tartaglia","year":"1997","unstructured":"Tartaglia M, Valeri S, Velardi F, Rocco CD, Battaglia PA (1997) Trp290Cys mutation in exon IIIa of the fibroblast growth factor receptor 2 (FGFR2) gene is associated with Pfeiffer syndrome. Hum Genet 99:602\u2013606","journal-title":"Hum Genet"},{"key":"1792_CR34","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1093\/hmg\/6.10.1647","volume":"6","author":"AO Wilkie","year":"1997","unstructured":"Wilkie AO (1997) Craniosynostosis: genes and mechanisms. Hum Mol Genet 6:1647\u20131656","journal-title":"Hum Mol Genet"},{"key":"1792_CR35","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/(SICI)1096-8628(19980123)75:3<252::AID-AJMG4>3.0.CO;2-S","volume":"75","author":"F Schaefer","year":"1998","unstructured":"Schaefer F, Anderson C, Can B, Say B (1998) Novel mutation in the FGFR2 gene at the same codon as the Crouzon syndrome mutations in a severe Pfeiffer syndrome type 2 case. Am J Med Genet 75:252\u2013255","journal-title":"Am J Med Genet"},{"key":"1792_CR36","doi-asserted-by":"crossref","first-page":"12555","DOI":"10.1073\/pnas.0405031101","volume":"101","author":"VP Eswarakumar","year":"2004","unstructured":"Eswarakumar VP, Horowitz MC, Locklin R, Morriss-Kay GM, Lonai P (2004) A gain-of-function mutation of Fgfr2c demonstrates the roles of this receptor variant in osteogenesis. Proc Natl Acad Sci U S A 101:12555\u201312560","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1792_CR37","doi-asserted-by":"crossref","first-page":"3783","DOI":"10.1242\/dev.129.16.3783","volume":"129","author":"VP Eswarakumar","year":"2002","unstructured":"Eswarakumar VP, Monsonego-Ornan E, Pines M, Antonopoulou I, Morriss-Kay GM et al (2002) The IIIc alternative of Fgfr2 is a positive regulator of bone formation. Development 129:3783\u20133793","journal-title":"Development"},{"key":"1792_CR38","doi-asserted-by":"crossref","first-page":"7894","DOI":"10.1073\/pnas.93.15.7894","volume":"93","author":"BD Galvin","year":"1996","unstructured":"Galvin BD, Hart KC, Meyer AN, Webster MK, Donoghue DJ (1996) Constitutive receptor activation by Crouzon syndrome mutations in fibroblast growth factor receptor (FGFR)2 and FGFR2\/Neu chimeras. Proc Natl Acad Sci U S A 93:7894\u20137899","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1792_CR39","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/(SICI)1097-4652(199707)172:1<117::AID-JCP13>3.0.CO;2-9","volume":"172","author":"K Mangasarian","year":"1997","unstructured":"Mangasarian K, Li Y, Mansukhani A, Basilico C (1997) Mutation associated with Crouzon syndrome causes ligand-independent dimerization and activation of FGF receptor-2. J Cell Physiol 172:117\u2013125","journal-title":"J Cell Physiol"},{"key":"1792_CR40","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.1242\/dev.01914","volume":"132","author":"Y Wang","year":"2005","unstructured":"Wang Y, Xiao R, Yang F, Karim BO, Iacovelli AJ et al (2005) Abnormalities in cartilage and bone development in the Apert syndrome FGFR2+\/S252W mouse. Development 132:3537\u20133548","journal-title":"Development"},{"key":"1792_CR41","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1597\/05-212","volume":"43","author":"CA Perlyn","year":"2006","unstructured":"Perlyn CA, DeLeon VB, Babbs C, Govier D, Burell L et al (2006) The craniofacial phenotype of the Crouzon mouse: analysis of a model for syndromic craniosynostosis using three-dimensional microCT. Cleft Palate Craniofac J 43:740\u2013748","journal-title":"Cleft Palate Craniofac J"},{"key":"1792_CR42","doi-asserted-by":"crossref","first-page":"3855","DOI":"10.1073\/pnas.071586898","volume":"98","author":"MK Hajihosseini","year":"2001","unstructured":"Hajihosseini MK, Wilson S, De Moerlooze L, Dickson C (2001) A splicing switch and gain-of-function mutation in FgfR2-IIIc hemizygotes causes Apert\/Pfeiffer-syndrome-like phenotypes. Proc Natl Acad Sci U S A 98:3855\u20133860","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1792_CR43","doi-asserted-by":"crossref","first-page":"11895","DOI":"10.1073\/pnas.96.21.11895","volume":"96","author":"E Arman","year":"1999","unstructured":"Arman E, Haffner-Krausz R, Gorivodsky M, Lonai P (1999) Fgfr2 is required for limb outgrowth and lung-branching morphogenesis. Proc Natl Acad Sci U S A 96:11895\u201311899","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1792_CR44","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/5096","volume":"21","author":"K Sekine","year":"1999","unstructured":"Sekine K, Ohuchi H, Fujiwara M, Yamasaki M, Yoshizawa T et al (1999) Fgf10 is essential for limb and lung formation. Nat Genet 21:138\u2013141","journal-title":"Nat Genet"},{"key":"1792_CR45","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1242\/dev.01690","volume":"132","author":"Z Steinberg","year":"2005","unstructured":"Steinberg Z, Myers C, Heim VM, Lathrop CA, Rebustini IT et al (2005) FGFR2b signaling regulates ex vivo submandibular gland epithelial cell proliferation and branching morphogenesis. Development 132:1223\u20131234","journal-title":"Development"},{"key":"1792_CR46","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1242\/dev.02175","volume":"133","author":"X Zhang","year":"2006","unstructured":"Zhang X, Stappenbeck TS, White AC, Lavine KJ, Gordon JI et al (2006) Reciprocal epithelial-mesenchymal FGF signaling is required for cecal development. Development 133:173\u2013180","journal-title":"Development"},{"key":"1792_CR47","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1053\/j.gastro.2006.02.018","volume":"130","author":"B Spencer-Dene","year":"2006","unstructured":"Spencer-Dene B, Sala FG, Bellusci S, Gschmeissner S, Stamp G et al (2006) Stomach development is dependent on fibroblast growth factor 10\/fibroblast growth factor receptor 2b-mediated signaling. Gastroenterology 130:1233\u20131244","journal-title":"Gastroenterology"},{"key":"1792_CR48","first-page":"163","volume":"29","author":"M Katoh","year":"2006","unstructured":"Katoh M, Katoh M (2006) FGF signaling network in the gastrointestinal tract\u2014review. Int J Oncol 29:163\u2013168","journal-title":"Int J Oncol"},{"key":"1792_CR49","doi-asserted-by":"crossref","first-page":"27292","DOI":"10.1074\/jbc.M600448200","volume":"281","author":"NE Hatch","year":"2006","unstructured":"Hatch NE, Hudson M, Seto ML, Cunningham ML, Bothwell M (2006) Intracellular retention, degradation, and signaling of glycosylation-deficient FGFR2 and craniosynostosis syndrome-associated FGFR2C278F. J Biol Chem 281:27292\u201327305","journal-title":"J Biol Chem"},{"key":"1792_CR50","doi-asserted-by":"crossref","first-page":"26037","DOI":"10.1074\/jbc.270.44.26037","volume":"270","author":"KM Neilson","year":"1995","unstructured":"Neilson KM, Friesel RE (1995) Constitutive activation of fibroblast growth factor receptor-2 by a point mutation associated with Crouzon syndrome. J Biol Chem 270:26037\u201326040","journal-title":"J Biol Chem"},{"key":"1792_CR51","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/ajmg.10449","volume":"113","author":"V Shotelersuk","year":"2002","unstructured":"Shotelersuk V, Ittiwut C, Srivuthana S, Mahatumarat C, Lerdlum S et al (2002) Distinct craniofacial-skeletal-dermatological dysplasia in a patient with W290C mutation in FGFR2. Am J Med Genet 113:4\u20138","journal-title":"Am J Med Genet"},{"key":"1792_CR52","first-page":"491","volume":"58","author":"GA Meyers","year":"1996","unstructured":"Meyers GA, Day D, Goldberg R, Daentl DL, Przylepa KA et al (1996) FGFR2 exon IIIa and IIIc mutations in Crouzon, Jackson-Weiss, and Pfeiffer syndromes: evidence for missense changes, insertions, and a deletion due to alternative RNA splicing. Am J Hum Genet 58:491\u2013498","journal-title":"Am J Hum Genet"},{"key":"1792_CR53","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/ajmg.1320450305","volume":"45","author":"MJ Cohen","year":"1993","unstructured":"Cohen MJ (1993) Pfeiffer syndrome update, clinical subtypes, and guidelines for differential diagnosis. Am J Med Genet 45:300\u2013307","journal-title":"Am J Med Genet"},{"key":"1792_CR54","first-page":"165","volume":"19","author":"C Chen","year":"2008","unstructured":"Chen C, Lin S, Su Y, Chien S, Tsai F et al (2008) Craniosynostosis and congenital tracheal anomalies in an infant with Pfeiffer syndrome carrying the W290C FGFR2 mutation. Genet Couns 19:165\u2013172","journal-title":"Genet Couns"},{"key":"1792_CR55","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/bdra.20287","volume":"76","author":"NAJ Oliveira","year":"2006","unstructured":"Oliveira NAJ, Alonso LG, Fanganiello RD, Passos-Bueno MR (2006) Further evidence of association between mutations in FGFR2 and syndromic craniosynostosis with sacrococcygeal eversion. Birth Defects Res A Clin Mol Teratol 76:629\u2013633","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"issue":"6","key":"1792_CR56","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1597\/09-115","volume":"47","author":"YA Zarate","year":"2010","unstructured":"Zarate YA, Putnam PE, Saal HM (2010) Intestinal malrotation in a patient with Pfeiffer syndrome type 2. Cleft Palate Craniofac J 47(6):638\u2013641","journal-title":"Cleft Palate Craniofac J"},{"key":"1792_CR57","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1002\/ajmg.1320450618","volume":"45","author":"MM Cohen","year":"1993","unstructured":"Cohen MM, Kreiborg S (1993) Visceral anomalies in the Apert syndrome. Am J Med Genet 45:758\u2013760","journal-title":"Am J Med Genet"},{"key":"1792_CR58","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1093\/hmg\/ddq045","volume":"19","author":"H Miraoui","year":"2010","unstructured":"Miraoui H, Ringe J, Haupl T, Marie PJ (2010) Increased EFG- and PDGFalpha-receptor signaling by mutant FGF-receptor 2 contributes to osteoblast dysfunction in Apert craniosynostosis. Hum Mol Genet 19:1678\u20131689","journal-title":"Hum Mol Genet"},{"key":"1792_CR59","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1042\/BJ20071594","volume":"413","author":"Z Ahmed","year":"2008","unstructured":"Ahmed Z, Schuller AC, Suhling K, Tregidgo C, Ladbury JE (2008) Extracellular point mutations in FGFR2 elicit unexpected changes in intracellular signalling. Biochem J 413:37\u201349","journal-title":"Biochem J"},{"key":"1792_CR60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/0264-6021:3480001","volume":"348","author":"A Parodi","year":"2000","unstructured":"Parodi A (2000) Role of N-oligosaccharide endoplasmic reticulum processing reactions in glycoprotein folding and degradation. Biochem J 348:1\u201313","journal-title":"Biochem J"},{"key":"1792_CR61","doi-asserted-by":"crossref","first-page":"18603","DOI":"10.1073\/pnas.0609157103","volume":"103","author":"VP Eswarakumar","year":"2006","unstructured":"Eswarakumar VP, \u00d6zcan F, Lew ED, Bae JH, Tom\u00e9 F et al (2006) Attenuation of signaling pathways stimulated by pathologically activated FGF-receptor 2 mutants prevents craniosynostosis. Proc Natl Acad Sci U S A 103:18603\u201318608","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Child's Nervous System"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00381-012-1792-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00381-012-1792-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00381-012-1792-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,25]],"date-time":"2022-01-25T20:41:54Z","timestamp":1643143314000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00381-012-1792-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,8]]},"references-count":61,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["1792"],"URL":"https:\/\/doi.org\/10.1007\/s00381-012-1792-y","relation":{},"ISSN":["0256-7040","1433-0350"],"issn-type":[{"value":"0256-7040","type":"print"},{"value":"1433-0350","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8,8]]}}}